On the treatment of hemorrhage in patients with hemophilia and associated inhibitors.
作者信息
Tarantino M, Aledort L
出版信息
Transfusion. 2001 Dec;41(12):1628-9. doi: 10.1046/j.1537-2995.2001.41121628.x.
Abstract
摘要
相似文献
1
On the treatment of hemorrhage in patients with hemophilia and associated inhibitors.
Transfusion. 2001 Dec;41(12):1628-9. doi: 10.1046/j.1537-2995.2001.41121628.x.
2
Therapeutic decision-making in inhibitor patients.
Am J Hematol. 2006 Jan;81(1):71-2. doi: 10.1002/ajh.20474.
3
The use of agents that by-pass factor VIII inhibitors in patients with haemophilia.
Vox Sang. 1999;77 Suppl 1:38-41. doi: 10.1159/000056714.
4
A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors.
Haemophilia. 2001 Sep;7(5):532-4. doi: 10.1046/j.1365-2516.2001.0537a.x.
5
Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
Am J Hematol. 2002 Aug;70(4):333. doi: 10.1002/ajh.10164.
6
Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
Haematologica. 2004 Jun;89(6):759-61.
7
The concept of recombinant factor VIIa megadose for treating bleeding episodes in high-titer inhibitor patients with hemophilia: toward an expanding indication?
J Thromb Haemost. 2003 Mar;1(3):423-4. doi: 10.1046/j.1538-7836.2003.00058.x.
8
Suggestions for the management of factor VIII inhibitors.
Haemophilia. 2000 Jul;6 Suppl 1:52-9.
9
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
Br J Haematol. 2013 Jan;160(2):153-70. doi: 10.1111/bjh.12091. Epub 2012 Nov 15.
10
Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait.
Haemophilia. 1999 Jul;5(4):273-5. doi: 10.1046/j.1365-2516.1999.00314.x.
Zotero 插件